Late Stage Life Cycle Management
The Pillars of Pharmaceutical and Biotech Success
SAI MedPartners helps assess the competitive landscape and identify threats to your assets during LoE (loss of exclusivity) planning, whether tracking generic activity in small molecules or evaluating biosimilar developers in biologics, to establish an effective life cycle management (LCM) strategy.
Benchmarking Support to Drive Key Manufacturing Goals: Efficiency, COGS, and Capacity
GENERICS MARKET ENTRY
SAI Delivers Essential Insights on Key Life Cycle Management Strategies as Your Brand Approaches Generic Competition
WHAT?
Effective LCM requires evaluating the key threats facing each brand.
WHEN?
Anticipating the timing of generics market entry is essential to effectively managing the LoE point.
WHO?
Profiling competitors and their capabilities is vital for effectively analyzing the competitive landscape.
HOW MANY?
The number of market players impacts potential price erosion scenarios.
WHY?
Understanding how generic firms evaluate targets is crucial for shaping effective LCM strategies.
WHERE?
Emerging markets present unique dynamics that impact LCM strategies.
Three Pillars of Success: Expert Solutions for Navigating Generics
Navigating the complexities of the generics market is key to successful life cycle management. At SAI MedPartners, we rely on three core pillars to provide life cycle management solutions that help your brand confidently handle generic competition while maintaining market leadership.
1. Expert Advice
- A project team comprised of seasoned generics industry executives provides valuable insights and recommendations for every engagement
- Expert advice drives our analysis, synthesis, and recommendations, preparing your brand for market challenges and opportunities
2. Methodological Rigor
- Structured, proven methodology refined over years based on numerous successful engagements
- Commitment to best practices and delivery of tailored strategies with the highest level of rigor
- Delivery of precise, actionable insights tailored for your needs
3. Global Understanding
- Extensive knowledge of core generics markets and emerging sectors
- Awareness of key market dynamics across the globe
- Development of innovative and effective strategies to maintain a competitive edge
Partnering for Success in the Complex Biosimilars Landscape
SAI MedPartners conducts in-depth assessments to analyze the competitive landscape and identify critical success factors across global markets. Our expertise in biosimilars helps clients stay ahead of market trends, anticipate challenges, and capitalize on opportunities in this unique sector.
Our solutions are customized to help you navigate this evolving landscape with clarity and confidence.
- Map supply chains
- Define partnerships and alliances
- Evaluate launch impact and timing
- Assess in-market dynamics
- Identify risks and opportunities
- Unravel uncertainty
Optimizing Supply Chain and Manufacturing Excellence
At SAl MedPartners, we recognize that a resilient and optimized supply chain is critical to success in the pharmaceutical and biotech sectors. Our extensive network, spanning manufacturing, third-party logistics (3PL), and global distribution facilities, ensures efficiency and reliability across your operations. With deep expertise in supply chain management and manufacturing, we provide insights and strategies that empower you to maintain a competitive edge in a dynamic global market.
